In HER2-positive breast cancer cells, AR promotes the expression of the HER3 gene, and the HER2/HER3 heterodimer activates the PI3K/AKT pathway and the MYC gene and promotes cell proliferation. Here, ERBB3 is linked to breast carcinoma.